Biogen

• 1/30/2025

  Biotech Showdown: Sage Rejects Biogen’s $469M Bid

• 1/26/2025

  Johnson & Johnson’s Path to Long-Term Growth Amidst Challenges

• 1/18/2025

  Biotech Bombshell: Biogen’s Surprise Bid for Sage Therapeutics

• 1/15/2025

  Biotech Giant’s High-Stakes Gamble on In-House Innovation

• 11/3/2024

  Biogen’s Q3 Earnings Beat Expectations, Driven by Alzheimer’s Breakthrough